Naloxegol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Naloxegol. Educational only — not medical advice.
Labeled uses
MOVANTIK ® is indicated for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.
Source: FDA labeling via NIH DailyMed (set 300a6474…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.